National Institute on Drug Abuse; Amended Notice of Meeting
---
identifier: "/us/fr/2023-19406"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute on Drug Abuse; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2023-19406"
section_name: "National Institute on Drug Abuse; Amended Notice of Meeting"
positive_law: false
currency: "2023-09-08"
last_updated: "2023-09-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2023-19406"
document_type: "notice"
publication_date: "2023-09-08"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "88 FR 62097"
fr_volume: 88
---
# National Institute on Drug Abuse; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Advisory Council on Drug Abuse, September 12, 2023, 10:30 a.m. to September 12, 2023, 05:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the *Federal Register* on August 21, 2023, FR Doc 2023-17889, 88 FR 56847.
This notice is being amended to change the open session start time from 12:45 p.m. to 1:00 p.m. The open session will now be held from 1:00 p.m. to 5:00 p.m. on September 12, 2023. The meeting is partially closed to the public.
Dated: September 1, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.